To carry out their activities, Research Teams of the Frédéric Joliot Institute for Life Sciences have developed high-profile technological platforms in many areas : biomedical imaging, structural biology, metabolomics, High-Throughput screening, level 3 microbiological safety laboratory...
Within the Institute, the "Funding Research and Technology Transfer" team is at your disposal to identify the scientists and the skills you need to set up a joint project, to define the terms of a collaboration contract or study.
Whether you are an academic, a SME or an industrialist, our team informs and advices you about the possibilities of consortium assembly, technology transfer, patent licensing or use of our platforms.
The team is also at the disposal of the researchers of the institute to accompany them in achieving their valorization objectives.
All the news of the Institute of life sciences Frédéric Joliot
Scientific result | Fundamental Research | Health ＆ life sciences | Biotechnology
Researchers from I2BC (SBIGeM), in collaboration with teams from Sorbonne University, have characterized cyclodipeptide oxidases in vivo and shown that they are valuable tools for producing dehydrogenated 2,5-diketopiperazines, precursors of bioactive molecules of pharmaceutical interest, in Escherichia coli using synthetic biology approaches.
2,5-diketopiperazines (2,5-DKP), produced by fungi, bacteria, plants and animals, have properties (antibacterial, antiviral, anticancer or anti-inflammatory) that make them very attractive for pharmacopoeia. The I2BC team (SBIGeM) has been studying for several years the bacterial biosynthetic pathways of these molecules and exploits them, in collaboration with teams from the Sorbonne University, to develop synthetic biology processes to produce 2,5-DKP in the chassis bacterium Escherichia coli. 2,5-DKPs are synthesized in several steps: cyclodipeptide synthases (CDPS) make cyclodipeptides from the amino acids loaded on the transfer RNAs (tRNAs), which are then modified by other enzymes to form 2,5-DKPs with remarkable biological properties. In the present study, the team focused on cyclodipeptide oxidases (CDOs). CDOs are involved early in the biosynthesis pathways of 2,5-DKPs and contribute to their chemical diversification by producing dehydrogenated 2,5-DKPs via a Ca-Cb dehydrogenation reaction. The objective of this study is to provide a toolbox for efficient bio-production in E coli of dehydrogenated 2,5-DKPs. To do this, researchers first analyzed bacterial genomes in order to identify genes coding for CDOs in the 2,5-DKP biosynthesis pathways. Six of these genes, corresponding to CDOs of unknown activity, were co-expressed in E coli with those coding for the associated CDPS. The chemical structure of the dehydrogenated cyclodipeptides thus produced in the culture supernatants was resolved to characterize the enzymatic activity of the studied CDOs. In a second step, in order to optimize the bio-production of these dehydrogenated 2,5-DKP in E coli, combinatorial engineering was carried out : each of the genes coding for the six CDOs studied as well as for two previously characterized CDOs was co-expressed with one of the eighteen genes coding for a CDPS. Among the 144 combinations, the best CDO/CDPS pairs (allowing the production of the highest levels of many dehydrogenated 2,5-DKPs) were identified.
F Le Chevalier, I Correia, L Matheron, M Babin, M Moutiez, N Canu, M Gondry, O Lequin, P Belin. In vivo characterization of the activities of novel cyclodipeptide oxidases: new tools for increasing chemical diversity of bioproduced 2,5‑diketopiperazines in Escherichia coli. Microb. Cell Fact. 2020 https://doi.org/10.1186/s12934-020-01432-y
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.